Healthcare provider profile · identity verified

Mary Kelli Smith, M.D.

Family Practice · COVINGTON, LA · NPI 1962451518

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	665	175
Pantoprazole Sodium	Pantoprazole Sodium	588	179
Amlodipine Besylate	Amlodipine Besylate	503	140
Losartan Potassium	Losartan Potassium	442	119
Atorvastatin Calcium	Atorvastatin Calcium	439	126
Escitalopram Oxalate	Escitalopram Oxalate	337	94
Gabapentin	Gabapentin	331	80
Rosuvastatin Calcium	Rosuvastatin Calcium	294	84
Metoprolol Succinate	Metoprolol Succinate	258	74
Trazodone Hcl	Trazodone Hcl	258	72
Pravastatin Sodium	Pravastatin Sodium	234	66
Hydrochlorothiazide	Hydrochlorothiazide	232	65
Omeprazole	Omeprazole	213	63
Metformin Hcl	Metformin Hcl	203	60
Ipratropium Bromide	Ipratropium Bromide	184	88
Simvastatin	Simvastatin	171	46
Furosemide	Furosemide	169	53
Eliquis	Apixaban	165	28
Glimepiride	Glimepiride	153	42
Meloxicam	Meloxicam	147	40
Montelukast Sodium	Montelukast Sodium	147	36
Famotidine	Famotidine	146	52
Alprazolam	Alprazolam	144	39
Venlafaxine Hcl Er	Venlafaxine Hcl	144	39
Lisinopril	Lisinopril	135	39
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	132	41
Ozempic	Semaglutide	129	21
Tizanidine Hcl	Tizanidine Hcl	124	37
Potassium Chloride	Potassium Chloride	115	33
Valsartan	Valsartan	106	28
Sertraline Hcl	Sertraline Hcl	103	32
Albuterol Sulfate Hfa	Albuterol Sulfate	101	40
Allopurinol	Allopurinol	98	26
Fluticasone Propionate	Fluticasone Propionate	98	44
Synthroid	Levothyroxine Sodium	95	24
Clopidogrel	Clopidogrel Bisulfate	90	25
Zolpidem Tartrate	Zolpidem Tartrate	90	23
Carvedilol	Carvedilol	84	16
Duloxetine Hcl	Duloxetine Hcl	84	25
Tamsulosin Hcl	Tamsulosin Hcl	84	30
Esomeprazole Magnesium	Esomeprazole Magnesium	80	20
Bupropion Xl	Bupropion Hcl	78	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	22
Oxybutynin Chloride Er	Oxybutynin Chloride	74	25
Doxepin Hcl	Doxepin Hcl	72	17
Buspirone Hcl	Buspirone Hcl	71	23
Spironolactone	Spironolactone	71	17
Fluoxetine Hcl	Fluoxetine Hcl	69	17
Tramadol Hcl	Tramadol Hcl	69	25
Ezetimibe	Ezetimibe	68	21
Metoprolol Tartrate	Metoprolol Tartrate	68	22
Alendronate Sodium	Alendronate Sodium	64	20
Jardiance	Empagliflozin	64	17
Irbesartan	Irbesartan	61	16
Atenolol	Atenolol	60	17
Metformin Hcl Er	Metformin Hcl	57	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	16
Estradiol	Estradiol	54	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	16
Fenofibrate	Fenofibrate	53	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	21
Linzess	Linaclotide	52	14
Olmesartan Medoxomil	Olmesartan Medoxomil	51	19
Celecoxib	Celecoxib	50	12
Mounjaro	Tirzepatide	50	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	11
Mirtazapine	Mirtazapine	48	16
Dicyclomine Hcl	Dicyclomine Hcl	47	14
Bupropion Hcl	Bupropion Hcl	42	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	18
Clonazepam	Clonazepam	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	suppressed
Telmisartan	Telmisartan	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	11
Diclofenac Sodium	Diclofenac Sodium	39	15
Januvia	Sitagliptin Phosphate	39	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	38	14
Azelastine Hcl	Azelastine Hcl	37	16
Ondansetron Odt	Ondansetron	37	18
Ibandronate Sodium	Ibandronate Sodium	36	15
Methylprednisolone	Methylprednisolone	36	35
Lorazepam	Lorazepam	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Creon	Lipase/Protease/Amylase	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	12
Fenofibrate	Fenofibrate,micronized	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	14
Triamcinolone Acetonide	Triamcinolone Acetonide	30	14
Pregabalin	Pregabalin	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	26
Tolterodine Tartrate Er	Tolterodine Tartrate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Ramipril	Ramipril	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Sucralfate	Sucralfate	25	13
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Cefdinir	Cefdinir	24	23
Donepezil Hcl	Donepezil Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	11
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Febuxostat	Febuxostat	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Colesevelam Hcl	Colesevelam Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Naproxen	Naproxen	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Verapamil Sr	Verapamil Hcl	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Benazepril Hcl	Benazepril Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Baclofen	Baclofen	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Nystatin	Nystatin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Belsomra	Suvorexant	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error